http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk#head http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk#assertion http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk#provenance http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk#publicationInfo http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk#assertion http://bio2rdf.org/drugbank:DB01393 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB01393_DB01432 http://bio2rdf.org/drugbank:DB01432 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB01393_DB01432 http://bio2rdf.org/drugbank_resource:DB01393_DB01432 http://purl.org/dc/terms/identifier drugbank_resource:DB01393_DB01432 http://bio2rdf.org/drugbank_resource:DB01393_DB01432 http://purl.org/dc/terms/title DDI between Bezafibrate and Cholestyramine - Bile acid sequestrants like cholestyramine may decrease the absorption of fibric acid derivatives like bezafibrate. Therapy modification should be considered. If concomitant therapy is used, separate doses by at least 2 hours to minimize this interaction. Fenofibric acid labeling recommends administration one hour prior to or 4-6 hours after a bile acid sequestrant. http://bio2rdf.org/drugbank_resource:DB01393_DB01432 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB01393_DB01432 http://www.w3.org/2000/01/rdf-schema#label DDI between Bezafibrate and Cholestyramine - Bile acid sequestrants like cholestyramine may decrease the absorption of fibric acid derivatives like bezafibrate. Therapy modification should be considered. If concomitant therapy is used, separate doses by at least 2 hours to minimize this interaction. Fenofibric acid labeling recommends administration one hour prior to or 4-6 hours after a bile acid sequestrant. [drugbank_resource:DB01393_DB01432] http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk#provenance http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk#publicationInfo http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk#signature.MCwCFBgdaCDO_9ar http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk#signature.MCwCFBgdaCDO_9ar http://purl.org/nanopub/x/hasSignature MCwCFBgdaCDO/9ar8F5DWR5kf8qjEO77AhQDstswWmHhiBr1HF/e7oFZgFMcBg== http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk#signature.MCwCFBgdaCDO_9ar http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk http://purl.org/dc/terms/created 2018-03-30T11:13:10.371+02:00 http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk#signature.MCwCFBgdaCDO_9ar http://bio2rdf.org/drugbank_resource:DB01393_DB01432_nanopub.RAPXlur2QWITmferSABd2OngBpy68cLorF5DBhh3VjvXk http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234